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Abstract
Objective To provide the first quantitative data on the use of the term
“placebo” in the 19th century.
Design Computer search of BMJ’s archival database from January 1840
(the first issue) through December 1899 for uses of the words
“placebo(s).” Grounded theory was used to categorise the implications
of uses of the term.
Results 71 citations contained the term “placebo(s).” Of these, 22 (31%)
used the term to mean “no effect” or as a general pejorative term, 18
(25%) portrayed placebo treatment as permitting the unfolding of the
natural history (the normal waxing and waning of illness), 14 (20%)
described placebo as important to satisfy patients, 7 (10%) described it
as fulfilling a physician’s performance role, 3 (4%) described its use to
buy time, 3 (4%) described its use for financial gain, 2 (3%) used it in a
manner similar to a placebo control, and only one implied that placebo
could have a clinical effect. Only one citation mentioned telling the patient
about his placebo treatment.
Conclusion Nineteenth century physicians had diverse a priori
assumptions about placebos. These findings remind us that
contemporary medicine needs to use rigorous science to separate fact
from its own beliefs concerning the “provision of care.” As in previous





to affect health outcomes, especially those based on subjective
self appraisal.
1 Furthermore, administrating placebos
deceptively, outside of the concealed context of clinical trials
withinformedconsent,isconsideredunethical.
2Historianshave
noted that such contemporary notions of placebo gained
acceptance only after the second world war with the
development and adoption of the randomised controlled trial.
3 4
It is thought that in earlier periods placebos were deceptively
and routinely used in clinical practice and considered an
innocuous “pious fraud” to placate “ignorant… disappointed
…andincurablecases.”
5Patientsreportingimprovementsfrom
placebo were experiencing “imaginary” symptoms.
3 This
understanding of placebo history is based on non-systematic
archival evidence and qualitative descriptions. We sought to
provide quantitative historical data on placebo use in the 19th
century.
Methods
We included all BMJ articles, reports, and letters between the
datesofJanuary1840,thefirstyearofthejournal’spublication,
and December 1899. We chose the BMJ for the availability of
itsonlinehistoricaldatabase,itsprominence,andthelikelihood
that it represented the medical profession’s practices and
attitudes. We searched the BMJ database with the terms
“placebo” “placebos” and “placebo effect.” We used methods
fromgroundedtheorytocategorisecitationsaccordingtotheme.
6
(See supplementary material on bmj.com for list of of full
methods, all citations found, and types of article)
Results
Wefound71citationsfor“placebo.”Allqueriesfor“placebos”
yielded the same 71 articles, and we found no articles that
mentioned “placebo effect.” Forty seven of the citations (66%)
wereinspecificsectionsoftheBMJ(suchas“Correspondence”
(10%), “Original communications” (10%), and “Reports of
societies” (4%), with the remaining 42% distributed among 23
Correspondence to:T J Kaptchuk ted_kaptchuk@hms.harvard.edu
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RESEARCHother categories). Twenty four of the citations (34%) were in
non-specified sections.
Using grounded theory, we distinguished nine categories for
the use of “placebo” in the 71 articles (although there were 75
individual mentions of “placebo” in all): no effect or pejorative
(31%), natural history (25%), satisfy patient (20%), medical
performance(10%),buytime(4%),financialgain(4%),placebo
control (3%), has clinical effect (1%), and unclear (1%) (see
table⇓). These categories are further explained and connected
with illustrative examples below.
No effect or pejorative—The commonest use of “placebo” was
in a derogatory manner to denote therapy that was ineffective
or harmless or valuable only for imaginary therapies. A typical
comment was placebos are an “innocent deception on our
hypochondriacal and fanciful patients”.
7 The idea of an
ineffective placebo was also emphasised in pejorative
descriptionsofunorthodoxpractitioners.“Itisnotanuncommon
occurrence for a sick person to go to the nearest apothecary,
and get one of the assistants to prescribe some placebo for the
more trivial complaints.”
8 Homeopathic medicine gives
“globules as placebos.”
9 We decided to combine “no effect”
and“pejorative”becauseitwasoftendifficulttodecidewhether




a healthy diet, and proper care. For example, physicians wrote
that giving placebos provided an opportunity “to place the
patientincircumstancesasfavorableaspossibletothesanative
operations of nature.”
10 Another physician reports on a visit to
Persia, where a traditional healer, or hakim, “leaves his patient
very much to nature, prescribing merely placebos.”
11
Satisfy patient—We put an article into this category when there
was some indication that the desire for a treatment came from
the patient. For example, a fever was treated with “a saline
mixture, with nitric aether, (more as a placebo than because he
really seemed in want of medicine).”
12 A bandage was applied
to a man’s arm “as a placebo to satisfy the patient.”
13 Included
in this category are cases where the physician dispenses a
placebo to calm the patient. A physician described other
physicians treating patients with diarrhoea from the “fear only”
of cholera, “who upon discovering this, gave mere placebos to
theirpatients,whoflockedtotheminshoalsduringthepanic.”
14
Performance—In these citations physicians described their use
of placebo as fulfilling the requirements of their professional
role. There was no contextual implication of patient request;
thebehaviourseemedselfgenerated.When“thepatientsuffered
from disease in which the organs were so profoundly altered
that it was little use attempting to prescribe anything more than
a series of placebos.”
15 Another physician reports “while
examining her she passed a watery evacuation involuntarily on
her bed. I had to do something, so I resorted to the blister over
the vagus, and left a lavender water placebo to be given.”
16
Buy time—Three citations described situations where placebo
was given to patients for extended periods of time or to extend
the time for the physician to make a diagnosis. One physician
describes how he used a placebo for three years while he
experimentedtomakelaxtympanicmembranestense.
17Inorder
to determine a patient’s “type of appendicitis,” another doctor
advocated “a carminative placebo” and making a second visit
four hours later.
18
Financial gain—Three articles clearly suggested that placebos
concerned financial incentives. One physician described how
“some medical men” with “starving families” would “give
globulesasplacebos.”
19Whiletheauthorexpressedcompassion
for his peers, he stressed drawing a “broad line between
medicineandhomeopathy”andremindedhispeerstonotbarter
“principle for pelf [wealth].” Another article described the
opportunity of some physicians to “swell up the bill” and
prescribe an “aqua col. or placebo prescription.”
20
Placebo control—Two articles used placebo as a research tool,
probablytoensureblindassessment.Bothtookplaceinthelate
19th century when orthodox medicine began to have interest in
blind assessment.
4 In one experiment, concerning amblyopia
(n=20), performed in 1886, a physician gave “half the cases
strychnine” and “in the other half a placebo, with apparently
equallygoodresults.”
21Anotherexperiment,performedin1889,
tested whether mercuric iodide had value for scarlet fever. The
physician “treated three series of eight cases each
simultaneously, with iron, mercuric chloride, and a placebo,
and, on the whole, the latter series did best.”
22
Has an effect or unclear—Only one citation was categorised as
having an effect on clinical outcomes. It was mentioned that in
cases of sleep anxiety, “a placebo administered with the
assurance that it is a powerful hypnotic” was “often
successful.”




Ethical issues (such as administering ineffective medicine,
quackery,earningextramoney)wereanoverlappingunderlying
theme in many of the articles. Our impression is that placebos
were largely administered deceptively, and patients were never
told of the “pious fraud.” Only one case reported disclosure. A
placebo, disguised as morphine was given to a patient with
morphine addiction. Three months later, during the follow-up
visit, the physician reported having “a good laugh [with the





Our sample is limited to a single journal, the BMJ. We selected
it because it is one of the oldest continuous medical journals in
the world with an electronically searchable database, and
because of its affiliation with the British Medical Association
(BMA). We could have expanded our numbers by using the
databases of other journals, but we decided that limiting our
search to a single journal would provide a valuable proof of
principle that quantitative methods could illuminate the history
of placebos. Verification in other electronically accessible
journals is warranted.
Conclusions
A priori beliefs concerning dummy treatments have been
rampant throughout history. In the 19th century, physicians
considered placebos to have no impact on clinical outcomes.
The idea of what Stuart Wolf first called, in 1950, “the placebo
effect” did not exist.
26 27 Recently, there has been interest in the




will correct our own contemporary a priori beliefs concerning
placebos and the “provision of care.” Discovering exactly what
effect the ritual of medicine has is important for a full
understanding of clinical practice and healthcare policy. An
expanded understanding of the underlying neuroscience of
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RESEARCHplacebo effects should also help to make vague beliefs more
precise.
28 Furthermore the absence of an ethical discussion on
placebo use in the 19th century and our own hidden use of
placebos in clinical practice
29 should remind us that an ethical
examination of placebo remains a critical challenge for
medicine.
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Table 1| Primary categories of use of the term “placebo” in 71 citations in BMJ 1840–99
No (%) of citations Category
22 (31%) No effect or pejorative
18 (25%) Natural history
14 (20%) Satisfy patient
7 (10%) Performance
3 (4%) Buy time
3 (4%) Financial gain
2 (3%) Placebo control
1 (1%) Has an effect
1 (1%) Unclear
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